top of page
Browse by category
Search
GLP-1s cut alcohol intake by almost two-thirds
Individuals who take liraglutide or semaglutide for weight loss reduced their alcohol consumption by almost two-thirds in four months,...
16.7% average weight loss on GLP-1 micro-dosing of 1.08 mg semaglutide per week
In one of the largest and longest real-world obesity studies to date that tracked nearly 2,700 adults over 64 weeks found patients...
Endoscopic sleeve gastroplasty gains momentum as a step forward in obesity care
About one in six European adults now live with obesity, putting them at greater risk for type 2 diabetes, heart disease and some...
Proportion of adolescents living with overweight and obesity in England increased by 50% between 2008 and 2023
The proportion of adolescents living with overweight or obesity in England has increased by 50% from 2008-2010 (22%) to 2021-2023 (33%),...
Targeting percentage weight loss targets is the wrong objective
Weight loss programmes targeting a particular percentage of weight loss are often failing, and that other factors should be considered...
GLP-s are safe and effective for treating obesity in adults with mental illness
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in adults with...
Browse by tag
bottom of page